Ofatumumab-associated colitis: A case report

This case suggests a potential class effect of anti-CD20 therapies, including ofatumumab, in relation to colitis in MS. Clinicians should monitor for gastrointestinal symptoms in MS patients receiving any anti-CD20 therapy.

Authors

Institutions

Publication Details

Journal
Multiple Sclerosis Journal
Published
2024-12-07
DOI
https://doi.org/10.1177/13524585241303479
Citations
6
Primary Topic
Multiple Sclerosis Research Studies
Type
article
Field-Weighted Citation Impact
2.55
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Ofatumumab-associated colitis: A case report

A. Connors, A. Patel, Megan Esch
6 citations
Multiple Sclerosis Journal
Multiple Sclerosis Research Studies
2.55
article

Ofatumumab-associated colitis: A case report

A. Connors, A. Patel, Megan Esch
article en
6 citations

Abstract

This case suggests a potential class effect of anti-CD20 therapies, including ofatumumab, in relation to colitis in MS. Clinicians should monitor for gastrointestinal symptoms in MS patients receiving any anti-CD20 therapy.

Multiple Sclerosis JournalVol. 31(2)
Geisinger Health System (US)
Good health and well-being
Openalex Percentile: Top 10%
Multiple Sclerosis Research Studies
2.55
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Ofatumumab-associated colitis: A case report — A. Connors, A. Patel, et al. · Multiple Sclerosis Journal (2024) | TGRS Research Map | TGRS